Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The European consensus on hepatitis C].

V Kolarski1

  • 1vkolapski@bsbg.net

Vutreshni Bolesti
|September 16, 2000
PubMed
Summary
This summary is machine-generated.

Newer Hepatitis C treatments combine higher interferon doses with ribavirin for improved efficacy. Experts discussed advanced therapies, including gene therapy, to combat this global health challenge.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cytokines and the liver in health and disease].

Vutreshni bolesti·2001
Same author

[Sodium in clinics and complications of liver cirrhosis].

Vutreshni bolesti·2001
Same author

[The immunological changes and prognosis of cholestatic jaundice in choledocholithiasis].

Khirurgiia·2000
Same author

[The extrahepatic manifestations in hepatitis C virus (HCV) infection].

Vutreshni bolesti·2000
Same author

[The systemic and local immune responses in patients with alcoholic liver cirrhosis depending on hepatitis C viral infection (HCV)].

Vutreshni bolesti·2000
Same author

[The treatment of primary biliary liver cirrhosis with ursodeoxycholic acid (preliminary report)].

Vutreshni bolesti·1991
Same journal

[Comparative analysis of blood and urinary electrolytes in normotensive and hypertensive normal, overweight and obese subjects aged 50-54 in the Bulgarian army].

Vutreshni bolesti·2002
Same journal

[Studies on restraint ulcers in rats in conditions of acute copper deficiency].

Vutreshni bolesti·2002
Same journal

[Congestive heart failure--some current problems].

Vutreshni bolesti·2002
Same journal

[Antioxidant parameters in metabolic syndrome -- a dynamic evaluation during oral glucose tolerance test].

Vutreshni bolesti·2002
Same journal

[Interleukins and endocrine function].

Vutreshni bolesti·2002
Same journal

[Longitudinal study of parameters of respiratory function tests and blood gas analysis in patients with progressive systemic scleroderma].

Vutreshni bolesti·2002
See all related articles

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • The European Association for the Study of the Liver (EASL) convened experts to address chronic Hepatitis C.
  • Hepatitis C represents a significant global health burden with ongoing therapeutic challenges.

Framework:

  • The 1999 EASL Consensus Conference focused on novel treatment strategies for chronic Hepatitis C.
  • Discussions included advancements in antiviral therapies and potential future interventions.

Implementation:

  • Higher doses of interferon (interferon-alpha or consensus interferon) combined with ribavirin for 12 months demonstrated improved treatment efficacy.
  • Investigated ultrarapid Hepatitis C Virus (HCV) clearance using high-dose interferon-alpha induction therapy with ribavirin.

Related Experiment Videos

Implications:

  • These findings suggested more effective treatment regimens for chronic Hepatitis C.
  • Gene therapy and genetic vaccines were explored as potential future solutions for HCV infection.
  • Anticipated resolution of most therapeutic problems for chronic Hepatitis C by 2010.